Thermo Fisher Scientific leads structurally, with stability as the clearest single gap between the two profiles. Biogen still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Biogen carries the stronger setup — intact trend against Thermo Fisher Scientific's broken trend. That leaves a split case: the structural lead stays with Thermo Fisher Scientific, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
Stability remains the main source of distance in the comparison.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
Most of the shared profile comes through revenue growth trajectory and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Thermo Fisher Scientific Inc. occupies the cheaper side of the setup map, although Biogen Inc. still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where BIIB and TMO each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The clearest distance comes from a steadier profile over time.
Absolute pricing still looks more supportive for Biogen, with a forward P/E that is 4.4 turns lower there.
Stability gives Thermo Fisher Scientific Inc. the clearer edge, even though valuation and the price setup keep the overall picture from looking clean.
Break down the BIIB vs TMO comparison across all dimensions with the full interactive tool.
Explore how BIIB and TMO each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.